ReviewFrontiers in immunology2017

Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics.

Peter Bannas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.